HALO
Halozyme Therape (HALO)
NASDAQ
$108.34+$0.17 (+0.16%)
Price as of Aug 21, 2026 7:42 PM EDT
  • $12.3B
    Market Cap
  • 50.61%
    1-Year Change
  • Biotechnology
    Industry
HALO
vs History
vs S&P 500
General Statistics
Latest Close
$108.17
Change
+$2.05 (+1.93%)
Open
$106.20
High
$108.49
Low
$105.91
Previous Close
$106.12
Volume
1,174,232
30-Day Average Volume
2,326,320
1-Week Change
9.64%
1-Month Change
37.62%
1-Year Change
50.61%
3-Year Change
153.80%
5-Year Change
173.50%
Fundamentals
Shares Outstanding
113.5M
Total Assets
$2.6B
Market Cap
$12.3B
Enterprise Value
$14.3B
Period:
QTR
TTM
FY
Revenue
$307.7M
Net Income
$229.9M
Free Cash Flow
$236.7M
EBIT
$285.3M
EBITDA
$314.8M
Net Working Capital
$588.6M
EPS
$1.90
Enterprise Value/EBITDA
45
Enterprise Value/Revenue
46
P/B
86
P/E
57
PEG
1
Price/Free Cash Flow
52
Price/Operating Cash Flow
51
Dividends & Splits
Forward Annual Dividend Yield
N/A
Trailing Annual Dividend Yield
N/A
Ex-Dividend Date
N/A
Last Split Factor
N/A
Last Split Date
N/A

Earnings & Revenue